Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Wednesday Trading
View:
Post by nodaytrader on Dec 15, 2021 12:25pm

Wednesday Trading

And here comes another one!
Comment by CASHEAGLE on Dec 16, 2021 8:28am
Please clarify your posts..here come another who/what?
Comment by CASHEAGLE on Dec 18, 2021 12:56am
AGN    is going to be $100 m once it hits NAsdaq...that s is just the valuation and  chris  Moreai has done this before..He works with promoy=ters and gets results..He too AGN from $.02 namd tarded 1B agn shares on covid fever  he qalmsot nlew $12M in phqse i on covid with zero to show. But he isno wonto a cough del that is going to be $1..it might repets his ...more  
Comment by Pandora on Dec 18, 2021 10:41pm
In attempting to read this post are we to assume it was done on a cell phone with fat fingers? That's the most common reason given for something like this. I have no idea what it is supposed to say.
Comment by nodaytrader on Dec 20, 2021 3:05pm
Follow the trades on www.thecse.com (search for AGN) You will see, almost invariably, following positive news from the company or where the outloo is generally positive, that the market price is driven down by small sales - usually involving the same players.
Comment by C10H12N2 on Dec 20, 2021 7:16pm
It's the story of Algernon's life on the CSE/OTC. UPLIST OR DIE
Comment by nodaytrader on Dec 21, 2021 11:10am
At the risk of seeming pedantic, perhaps "uplist or be killed"?
Comment by C10H12N2 on Dec 21, 2021 12:49pm
Pay attention. One is murder be killed). The other is natural cause (DIE). My response was in the context of what you wrote. Meaning, Algernon will continue to experience a slow death by not uplifting. Simply look at where the company is now compared to it's past. Historic low Float. Historic low Share Price. Historic low Market Cap. How low can Algernon go? SIX FEET DEEP. I've seen enough ...more  
Comment by Goldhog on Dec 21, 2021 3:29pm
Good one. I do think we uplist and score large from here
Comment by C10H12N2 on Dec 21, 2021 9:45pm
Yeah, it's critical Algernon uplist ASAP. Other than CSE-OTC being somewhat incompetent in understanding biotech valuatrions, the glaringv internal problem with algernon is it's timelines to get to data readouts. The CEO wants to consistently compare Algernon to Bellus Health in similar ways, but the absolutely most important way is an aggressive timeline to get to a data readout that ...more  
Comment by Whalewatcher1 on Dec 27, 2021 12:45pm
How does this stock get uplisted to Nasdaq? They will need major $ raise to meet minimum listing requiremts. Search for yourself the Nasdaq listing requirements including year plus cash based on market guidance on developments, capital, share price, director independence etc. these guys had $2.4M cash in August, spending $2M a quarter and $6M market cap. Do you really think nasdaq will accept them ...more